SEARCH

SEARCH BY CITATION

References

  • Betts M. J. and Russell R. B. (2003) Amino acid properties and consequences of substitutions,in Bioinformatics for geneticists (Barnes M. R. and Gray I. C., eds.), pp. 289316. Wiley, Hoboken, NJ.
  • Borchelt D. R., Lee M. K., Slunt H. S. et al. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl Acad. Sci. USA 91, 82928296.
  • Borchelt D. R., Guarnieri M., Wong P. C., Lee M. K., Slunt H. S., Xu Z. S., Sisodia S. S., Price D. L. and Cleveland D. W. (1995) Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. Biol. Chem. 270, 32343238.
  • Borchelt D. R., Wong P. C., Becher M. W. et al. (1998) Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice. Neurobiol. Dis. 5, 2735.
  • Bruijn L. I., Houseweart M. K., Kato S., Anderson K. L., Anderson S. D., Ohama E., Reaume A. G., Scott R. W. and Cleveland D. W. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 18511854.
  • Bruns C. K. and Kopito R. R. (2007) Impaired post-translational folding of familial ALS-linked Cu, Zn superoxide dismutase mutants. EMBO J. 26, 855866.
  • Bystrom R., Andersen P. M., Grobner G. and Oliveberg M. (2010) SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability. J. Biol. Chem. 285, 1954419552.
  • Chattopadhyay M. and Valentine J. S. (2009) Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid. Redox Signal. 11, 16031614.
  • Chattopadhyay M., Durazo A., Sohn S. H., Strong C. D., Gralla E. B., Whitelegge J. P. and Valentine J. S. (2008) Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc. Natl Acad. Sci. USA 105, 1866318668.
  • Cudkowicz M. E., Warren L., Francis J. W., Lloyd K. J., Friedlander R. M., Borges L. F., Kassem N., Munsat T. L. and Brown R. H., Jr (1997) Intrathecal administration of recombinant human superoxide dismutase 1 in amyotrophic lateral sclerosis: a preliminary safety and pharmacokinetic study. Neurology 49, 213222.
  • Deng H. X., Shi Y., Furukawa Y. et al. (2006) Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl Acad. Sci. USA 103, 71427147.
  • Doucette P. A., Whitson L. J., Cao X., Schirf V., Demeler B., Valentine J. S., Hansen J. C. and Hart P. J. (2004) Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability. J. Biol. Chem. 279, 5455854566.
  • Furukawa Y., Kaneko K., Yamanaka K., O'Halloran T. V. and Nukina N. (2008) Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 283, 2416724176.
  • Jaarsma D., Haasdijk E. D., Grashorn J. A., Hawkins R., van Duijn W., Verspaget H. W., London J. and Holstege J. C. (2000) Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7, 623643.
  • Jonsson P. A., Graffmo K. S., Andersen P. M., Brannstrom T., Lindberg M., Oliveberg M. and Marklund S. L. (2006) Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 129, 451464.
  • Karch C. M. and Borchelt D. R. (2008) A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J. Biol. Chem. 283, 1352813537.
  • Karch C. M., Prudencio M., Winkler D. D., Hart P. J. and Borchelt D. R. (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc. Natl Acad. Sci. USA 106, 77747779.
  • Lelie H. L., Liba A., Bourassa M. W. et al. (2011) Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. J. Biol. Chem. 286, 27952806.
  • Potter S. Z., Zhu H., Shaw B. F. et al. (2007) Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. J. Am. Chem. Soc. 129, 45754583.
  • Prudencio M. and Borchelt D. R. (2011) Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. Mol. Neurodegener. 6, 77.
  • Prudencio M., Durazo A., Whitelegge J. P. and Borchelt D. R. (2009a) Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. J. Neurochem. 108, 10091018.
  • Prudencio M., Hart P. J., Borchelt D. R. and Andersen P. M. (2009b) Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum. Mol. Genet. 18, 32173226.
  • Prudencio M., Durazo A., Whitelegge J. P. and Borchelt D. R. (2010) An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum. Mol. Genet. 19, 47744789.
  • Prudencio M., Lelie H., Brown H. H., Whitelegge J. P., Valentine J. S. and Borchelt D. R. (2012) A novel variant of human superoxide dismutase 1 harboring amyotrophic lateral sclerosis-associated and experimental mutations in metal-binding residues and free cysteines lacks toxicity in vivo. J. Neurochem. 121, 475485.
  • Ratovitski T., Corson L. B., Strain J., Wong P., Cleveland D. W., Culotta V. C. and Borchelt D. R. (1999) Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum. Mol. Genet. 8, 14511460.
  • Reissner K. J. and Aswad D. W. (2003) Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? Cell. Mol. Life Sci. 60, 12811295.
  • Rodriguez J. A., Shaw B. F., Durazo A. et al. (2005) Destabilization of apoprotein is insufficient to explain Cu, Zn-superoxide dismutase-linked ALS pathogenesis. Proc. Natl Acad. Sci. USA 102, 1051610521.
  • Sandelin E., Nordlund A., Andersen P. M., Marklund S. S. and Oliveberg M. (2007) Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins. J. Biol. Chem. 282, 2123021236.
  • Wang J., Slunt H., Gonzales V., Fromholt D., Coonfield M., Copeland N. G., Jenkins N. A. and Borchelt D. R. (2003) Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum. Mol. Genet. 12, 27532764.
  • Wang J., Xu G., Slunt H. H., Gonzales V., Coonfield M., Fromholt D., Copeland N. G., Jenkins N. A. and Borchelt D. R. (2005) Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol. Dis. 20, 943952.
  • Watanabe M., Dykes-Hoberg M., Culotta V. C., Price D. L., Wong P. C. and Rothstein J. D. (2001) Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 8, 933941.
  • Zetterstrom P., Stewart H. G., Bergemalm D., Jonsson P. A., Graffmo K. S., Andersen P. M., Brannstrom T., Oliveberg M. and Marklund S. L. (2007) Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc. Natl Acad. Sci. USA 104, 1415714162.